Transforaminal versus posterior lumbar interbody fusion for symptomatic single-level spondylolisthesis (LIFT): a multicentre controlled, patient blinded, randomised non-inferiority trial

https://www.thelancet.com/journals/lanepe/article/PIIS2666-7762(24)00131-5/fulltext?dgcid=hubspot_update_feature_updatealerts_lanepe&utm_campaign=update-lanepe&utm_medium=email&_hsenc=p2ANqtz-8PU7tbrslJavKCBDonRQy6InweP7lROYrsinXAA9EamKFdVVGCtgNBjjYOHV4JwEYsDbt82nzyGqRoaewhuLpG2XXt8w&_hsmi=319764010&utm_content=319691324&utm_source=hs_email